ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HSTC HST Global Inc (PK)

0.975
-0.005 (-0.51%)
Jun 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,573
Bid Price 0.85
Ask Price 1.11
News -
Day High 0.975

Low
0.1425

52 Week Range

High
1.15

Day Low 0.85
Company Name Stock Ticker Symbol Market Type
HST Global Inc (PK) HSTC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005 -0.51% 0.975 16:00:10
Open Price Low Price High Price Close Price Prev Close
0.85 0.85 0.975 0.975 0.98
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5 1,573 $ 0.858503 $ 1,350 - 0.1425 - 1.15
Last Trade Time Type Quantity Stock Price Currency
15:43:11 100 $ 0.975 USD

HST Global Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.09M 5.25M - 0 -146k -0.03 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HST Global (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HSTC Message Board. Create One! See More Posts on HSTC Message Board See More Message Board Posts

Historical HSTC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.04751.100.7241.051,553-0.0725-6.92%
1 Month1.101.100.7241.051,052-0.125-11.36%
3 Months0.851.150.650.94136961,2100.12514.71%
6 Months0.35021.150.35020.66644471,8960.6248178.41%
1 Year0.14251.150.14250.38025083,4190.8325584.21%
3 Years0.0911.150.0750.22171044,5690.884971.43%
5 Years0.01141.150.00450.032556232,1110.96368,452.63%

HST Global (PK) Description

HST Global, a publically held biotechnology and wellness company, discovers and develops breakthroughs in supporting and treating metabolic disorders associated with cancer and other life threatening illnesses. HST Global's new and novel therapeutic approaches positively impact patients with disorders associated with late stage cancer who are in need of supportive well-tolerated treatments. Through its proprietary scientific platform, HST Global is developing therapies that address metabolic deficiencies, dysfunction, or disorders, and provides an alternative source of support for patients.

Your Recent History

Delayed Upgrade Clock